These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 32217690)
1. Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells. Jin C; Zhu X; Wu H; Wang Y; Hu X J Biol Chem; 2020 May; 295(19):6425-6446. PubMed ID: 32217690 [TBL] [Abstract][Full Text] [Related]
2. Roles and mechanisms of phosphoglycerate kinase 1 in cancer. Chen Y; Cen L; Guo R; Huang S; Chen D Bull Cancer; 2022 Dec; 109(12):1298-1307. PubMed ID: 36096942 [TBL] [Abstract][Full Text] [Related]
3. The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme. Fiorillo A; Petrosino M; Ilari A; Pasquo A; Cipollone A; Maggi M; Chiaraluce R; Consalvi V PLoS One; 2018; 13(7):e0199191. PubMed ID: 29995887 [TBL] [Abstract][Full Text] [Related]
4. Perturbation of yeast 3-phosphoglycerate kinase reaction mixtures with ADP: transient kinetics of formation of ATP from bound 1,3-bisphosphoglycerate. Geerlof A; Travers F; Barman T; Lionne C Biochemistry; 2005 Nov; 44(45):14948-55. PubMed ID: 16274241 [TBL] [Abstract][Full Text] [Related]
5. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells. Fukushi A; Kim HD; Chang YC; Kim CH Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431 [TBL] [Abstract][Full Text] [Related]
6. Cryoenzymic studies on yeast 3-phosphoglycerate kinase. Attempt to obtain the kinetics of the hinge-bending motion. Geerlof A; Schmidt PP; Travers F; Barman T Biochemistry; 1997 May; 36(18):5538-45. PubMed ID: 9154937 [TBL] [Abstract][Full Text] [Related]
7. PGK1 : An Essential Player in Modulating Tumor Metabolism. Duncan L; Shay C; Teng Y Methods Mol Biol; 2022; 2343():57-70. PubMed ID: 34473315 [TBL] [Abstract][Full Text] [Related]
9. Targeting the Glycolytic Enzyme PGK1 to Inhibit the Warburg Effect: A New Strategy for Keloid Therapy. Wang P; Wang Q; Yang X; An Y; Wang J; Nie F; Pan B; Bi H; Qin Z Plast Reconstr Surg; 2023 Jun; 151(6):970e-980e. PubMed ID: 36728674 [TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nie H; Ju H; Fan J; Shi X; Cheng Y; Cang X; Zheng Z; Duan X; Yi W Nat Commun; 2020 Jan; 11(1):36. PubMed ID: 31911580 [TBL] [Abstract][Full Text] [Related]
11. Phosphoglycerate Kinases Are Co-Regulated to Adjust Metabolism and to Optimize Growth. Rosa-Téllez S; Anoman AD; Flores-Tornero M; Toujani W; Alseek S; Fernie AR; Nebauer SG; Muñoz-Bertomeu J; Segura J; Ros R Plant Physiol; 2018 Feb; 176(2):1182-1198. PubMed ID: 28951489 [TBL] [Abstract][Full Text] [Related]
12. Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. Wang S; Jiang B; Zhang T; Liu L; Wang Y; Wang Y; Chen X; Lin H; Zhou L; Xia Y; Chen L; Yang C; Xiong Y; Ye D; Guan KL PLoS Biol; 2015; 13(9):e1002243. PubMed ID: 26356530 [TBL] [Abstract][Full Text] [Related]
13. Human acylphosphatase cannot replace phosphoglycerate kinase in Saccharomyces cerevisiae. Van Hoek P; Modesti A; Ramponi G; Kötter P; van Dijken JP; Pron JT Antonie Van Leeuwenhoek; 2001 Oct; 80(1):11-7. PubMed ID: 11761363 [TBL] [Abstract][Full Text] [Related]
14. Determining the quantitative relationship between glycolysis and GAPDH in cancer cells exhibiting the Warburg effect. Zhu X; Jin C; Pan Q; Hu X J Biol Chem; 2021; 296():100369. PubMed ID: 33545174 [TBL] [Abstract][Full Text] [Related]
15. Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes. Ghashghaeinia M; Köberle M; Mrowietz U; Bernhardt I Cell Cycle; 2019 Jun; 18(12):1316-1334. PubMed ID: 31154896 [TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. Li X; Jiang Y; Meisenhelder J; Yang W; Hawke DH; Zheng Y; Xia Y; Aldape K; He J; Hunter T; Wang L; Lu Z Mol Cell; 2016 Mar; 61(5):705-719. PubMed ID: 26942675 [TBL] [Abstract][Full Text] [Related]
17. Phosphoglycerate Kinase 1: An Effective Therapeutic Target in Cancer. Qiu A; Wen X; Zou Q; Yin L; Zhu S; Sheng Y; He Y; Liu Q; Luo D; Guo Z Front Biosci (Landmark Ed); 2024 Mar; 29(3):92. PubMed ID: 38538272 [TBL] [Abstract][Full Text] [Related]
18. Substrate-assisted movement of the catalytic Lys 215 during domain closure: site-directed mutagenesis studies of human 3-phosphoglycerate kinase. Flachner B; Varga A; Szabó J; Barna L; Hajdú I; Gyimesi G; Závodszky P; Vas M Biochemistry; 2005 Dec; 44(51):16853-65. PubMed ID: 16363799 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52. Wang WL; Jiang ZR; Hu C; Chen C; Hu ZQ; Wang AL; Wang L; Liu J; Wang WC; Liu QS Acta Pharmacol Sin; 2021 Apr; 42(4):633-640. PubMed ID: 32737469 [TBL] [Abstract][Full Text] [Related]
20. A sandwich ELISA for phosphoglycerate kinase. Zhao W; Pao S; Malik F; Soh J; Fernandez S; Chirico WJ J Immunoassay Immunochem; 2008; 29(3):220-33. PubMed ID: 18569371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]